Previous 10 | Next 10 |
home / stock / alpmf / alpmf news
2024-04-24 11:12:04 ET Major earnings expected before the bell on Thursday include: Bristol-Myers Squibb ( BMY ) Caterpillar ( CAT ) Comcast ( CMCSA ) Altria Group ( MO ) Merck & Co ( MRK ) Read the full article on Seeking Alpha Fo...
2024-04-05 10:56:25 ET More on Ocugen Ocugen: A Speculative Buy In Biotech Growing Clinical Trials To Billion-Dollar Revenues Ocugen slips as accounting errors force restatements Ocugen shares make gains after US court dismisses class action lawsuits Seeking ...
2024-03-28 11:54:15 ET More on Astellas Pharma, Pfizer etc. Pfizer: Attractive Valuation And A Strong Pipeline Mitigate Patent Cliff Concerns Pfizer Inc. (PFE) Leerink Partners Global Biopharma Conference 2024 - (Transcript) Pfizer: Seagen Acquisition Starting To Bea...
2024-03-17 00:40:48 ET Summary Additional results from the phase 1 study, using P-BCMA-ALLO1 for the treatment of patients with relapsed/refractory multiple myeloma, are expected at AACR on April 8th of 2024; Other data 2nd half of 2024. The global multiple myeloma market size is ...
2024-02-05 13:08:05 ET Astellas Pharma Inc. (ALPMF) Q3 2023 Results Earnings Conference Call February 5, 2024, 02:00 AM ET Company Participants Hiromitsu Ikeda - Corporate Head, Advocacy & Relations Atsushi Kitamura - Chief Financial Officer Tadaaki Taniguchi...
2024-02-05 08:06:35 ET More on Astellas Pharma Astellas Pharma Inc. 2023 Q3 - Results - Earnings Call Presentation FDA denies approval of Astellas gastric cancer drug Astellas and Elpiscience collaborate for novel bi-specific macrophage engagers Historical ea...
2024-01-26 12:58:45 ET More on Merck Merck & Co., Inc. (MRK) JPMorgan 42nd Annual Healthcare Conference (Slides) Merck & Co., Inc. (MRK) Presents at JPMorgan 42nd Annual Healthcare Conference (Transcript) Merck's Soaring Stock: Examining The Euphoria Amidst P...
2024-01-26 07:39:18 ET More on Apellis Pharmaceuticals Apellis Pharmaceuticals: Focus Shifts Toward Market Share After Apparent Safety Resolution Apellis Pharmaceuticals, Inc. (APLS) Q3 2023 Earnings Call Transcript Apellis Pharmaceuticals, Inc. 2023 Q3 - Results - E...
2024-01-14 12:00:24 ET More on CRISPR, GSK, etc. Pfizer Is Part Of The 2024 Healthcare Sector Rally Cohort Impact Of Gene Therapies And Casgevy On Crispr AG And The Industry CRISPR Therapeutics AG (CRSP) 42nd Annual J.P. Morgan Healthcare Conference (Transcript) ...
2024-01-09 05:49:53 ET Japanese drugmaker Astellas Pharma ( OTCPK:ALPMY ) said on Monday that the U.S. Food and Drug Administration (FDA) has declined to approve the biologics license application of its experimental gastric cancer drug due to issues related to a third-party manufact...
News, Short Squeeze, Breakout and More Instantly...
Astellas Pharma Inc Company Name:
ALPMF Stock Symbol:
OTCMKTS Market:
Pharmaceutical stocks were initially expected to be largely immune to the COVID-19 economic downturn. Drugmakers, after all, generally produce products that are essential to daily life. However, the extreme social distancing that has become part and parcel of this unusual period has halted nume...
One of England's top healthcare watchdogs, the National Institute for Health and Care Excellence (NICE), has officially decided to stay the course and reject AstraZeneca 's (NYSE: AZN) lung cancer drug Tagrisso. A few months ago, the pharmaceutical giant argued that the drug should receive...
This past year proved profitable for investors in Incyte (NASDAQ: INCY) and Seattle Genetics (NASDAQ: SGEN) . Handily beating broad market and biotech indexes, these two drug manufacturers hit the $20 billion valuation mark and are poised to continue growing in the coming year -- unless, ...